Lipe & Dalton Abbott Laboratories Transaction History

Lipe & Dalton

$202 Million
Q4 2025

A detailed history of Lipe & Dalton transactions in Abbott Laboratories stock. As of the latest transaction made, Lipe & Dalton holds 1,020 shares of ABT stock, worth $132,630. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,020

Previous 1,730 41.04%

Holding current value

$132,630

Previous $235,000 45.53%

% of portfolio

0.06%

Previous 0.13%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 26, 2026	SELL	$123.62 - $134.59 $87,770 - $95,558	-710 Reduced 41.04%	1,020 $128,000
Q3 2025 Jan 26, 2026	BUY	$120.51 - $136.62 $49,409 - $56,014	410 Added 40.2%	1,430 $192,000
Q1 2025 May 05, 2025	BUY	$111.1 - $140.22 $192,203 - $242,580	1,730 New	1,730 $229,000
Q2 2024 Aug 02, 2024	SELL	$100.73 - $112.44 $3,424 - $3,822	-34 Reduced 1.69%	1,980 $206,000
Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $28,518 - $33,456	-300 Reduced 12.96%	2,014 $221,000

Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $3,928 - $4,809	34 Added 1.49%	2,314 $326,000
Q3 2021 Nov 01, 2021	SELL	$116.66 - $129.06 $17,499 - $19,359	-150 Reduced 6.17%	2,280 $269,000
Q4 2020 Jan 29, 2021	BUY	$105.0 - $114.42 $31,500 - $34,326	300 Added 14.08%	2,430 $266,000
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $1,636 - $1,774	-20 Reduced 0.93%	2,130 $178,000
Q2 2018 Aug 06, 2018	BUY	$57.57 - $63.54 $8,635 - $9,531	150 Added 7.5%	2,150 $131,000
Q1 2018 May 04, 2018	BUY	$56.27 - $63.62 $1,125 - $1,272	20 Added 1.01%	2,000 $120,000
Q2 2017 Aug 08, 2017	BUY	N/A	1,980	1,980 $96,000

Others Institutions Holding ABT

# of Institutions

3,644

Shares Held

1.39B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.

Account